Arama Sonuçları Diabetes - Daraltılmış: Novartis Foundation.
SirsiDynix Enterprise
https://katalog.hacettepe.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dDiabetes$0026qf$003dAUTHOR$002509Yazar$002509Novartis$002bFoundation.$002509Novartis$002bFoundation.$0026ps$003d300?dt=list
2024-11-22T19:38:03Z
Defining optimal immunotherapies for type 1 diabetes
ent://SD_ILS/0/SD_ILS:302539
2024-11-22T19:38:03Z
2024-11-22T19:38:03Z
Yazar Symposium on Defining Optimal Immunotherapies for Type 1 Diabetes (2007 : London, England) Bock, Gregory. Goode, Jamie. Novartis Foundation. Wiley InterScience (Online service)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim John Wiley <a href="http://dx.doi.org/10.1002/9780470697405">http://dx.doi.org/10.1002/9780470697405</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>
Fatty acids and lipotoxicity in obesity and diabetes
ent://SD_ILS/0/SD_ILS:302916
2024-11-22T19:38:03Z
2024-11-22T19:38:03Z
Yazar Symposium on Fatty Acids and Lipotoxicity in Obesity and Diabetes (2006 : Tsinghua University) Bock, Gregory. Goode, Jamie. Novartis Foundation. Qing hua da xue (Beijing, China)<br/>Yer Numarası ONLINE<br/>Elektronik Erişim HathiTrust Digital Library Limited view (search only) <a href="http://catalog.hathitrust.org/api/volumes/oclc/190776533.html">http://catalog.hathitrust.org/api/volumes/oclc/190776533.html</a>
John Wiley <a href="http://dx.doi.org/10.1002/9780470985571">http://dx.doi.org/10.1002/9780470985571</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>